Atlas Trials

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

Clinical trial NCT00428220 · COMPLETED

Trial details

NCT number
NCT00428220
Sponsor
Pfizer
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate CancerMetastatic Renal Cell CancerNon-Small Cell Lung CancerThyroid CancerAdvanced/Metastatic Non-Small Cell Lung CancerAdvanced Gastric CancerGastrointestinal Stromal TumorHepatocellular CarcinomaPancreatic Islet Cell CarcinomaPancreatic Neuroendocrine Tumor
Start date
2007-07-01
Primary completion
2014-08-01
Enrollment
223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.